PRESENTATION

There is a need for robust cellular assays and workflows that meet the demands of immunotherapy and cell therapy discovery, engineering, process development, and manufacturing.

Our new webinar will explore this emerging field with a focus on cell engineering solutions, real-time, reporter-based assays, and automated workflows. These solutions, together with physiological cellular models, are actively being used for screening, characterization, and manufacturing of immunotherapies and cellular therapies. We’ll also review real-world examples of how these assays are being applied.

• Discover how real-time cell analysis can be used to select and optimize chimeric antigen T (CAR-T) cells during discovery, method development, and manufacturing.
• Understand how to use emerging microplate reading and cellular imaging technologies to perform robust, reliable antibody-dependent and cell-mediated cytotoxicity assays.
• Explore techniques for gaining unique insights into the critical drivers behind immune cell function—and improving T cell persistence and antitumor potency.